145 related articles for article (PubMed ID: 32938553)
41. Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms.
Tsukagoshi M; Araki K; Saito F; Kubo N; Watanabe A; Igarashi T; Ishii N; Yamanaka T; Shirabe K; Kuwano H
Dig Dis Sci; 2018 Apr; 63(4):860-867. PubMed ID: 28667432
[TBL] [Abstract][Full Text] [Related]
42. Patterns of Recurrence After Resection of IPMN: Who, When, and How?
Marchegiani G; Mino-Kenudson M; Ferrone CR; Morales-Oyarvide V; Warshaw AL; Lillemoe KD; Castillo CF
Ann Surg; 2015 Dec; 262(6):1108-14. PubMed ID: 25793719
[TBL] [Abstract][Full Text] [Related]
43. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
[TBL] [Abstract][Full Text] [Related]
44. Limitations and prospects in the management of IPMN: a retrospective, single-center observational study.
Peisl S; Burckhardt O; Egger B
BMC Surg; 2023 Jan; 23(1):3. PubMed ID: 36611137
[TBL] [Abstract][Full Text] [Related]
45. [Synchronous malignant intraductal papillary mucinous neoplasms of the bile duct and pancreas requiring left hepatectomy and total pancreatectomy].
Moon DB; Lee SG; Jung DH; Park GC; Park YH; Park HW; Kim MH; Lee SK; Yu ES; Kim JH
Korean J Gastroenterol; 2014 Feb; 63(2):129-33. PubMed ID: 24561701
[TBL] [Abstract][Full Text] [Related]
46. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or less.
Jung W; Park T; Kim Y; Park H; Han Y; He J; Wolfgang CL; Blair A; Rashid MF; Kluger MD; Su GH; Chabot JA; Yang CY; Lou W; Valente R; Del Chiaro M; Shyr YM; Wang SE; van Huijgevoort NCM; Besselink MG; Yang Y; Kim H; Kwon W; Kim SW; Jang JY
Br J Surg; 2019 Dec; 106(13):1829-1836. PubMed ID: 31441048
[TBL] [Abstract][Full Text] [Related]
47. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
[TBL] [Abstract][Full Text] [Related]
48. Intraductal papillary mucinous neoplasms of the pancreas.
Tanaka M
Pancreas; 2014 Nov; 43(8):1136-40. PubMed ID: 25333396
[No Abstract] [Full Text] [Related]
49. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
[TBL] [Abstract][Full Text] [Related]
50. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm?
He J; Cameron JL; Ahuja N; Makary MA; Hirose K; Choti MA; Schulick RD; Hruban RH; Pawlik TM; Wolfgang CL
J Am Coll Surg; 2013 Apr; 216(4):657-65; discussion 665-7. PubMed ID: 23395158
[TBL] [Abstract][Full Text] [Related]
51. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
52. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
Schnelldorfer T; Sarr MG; Nagorney DM; Zhang L; Smyrk TC; Qin R; Chari ST; Farnell MB
Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
[TBL] [Abstract][Full Text] [Related]
53. Management of pancreatic intraductal papillary mucinous neoplasm in an academic hospital (2005-2010): what follow-up for unoperated patients?
Baiocchi GL; Portolani N; Grazioli L; Mazza G; Gheza F; Bartoli M; Vanzetti E; Giulini SM
Pancreas; 2013 May; 42(4):696-700. PubMed ID: 23160482
[TBL] [Abstract][Full Text] [Related]
54. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
[TBL] [Abstract][Full Text] [Related]
55. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
[TBL] [Abstract][Full Text] [Related]
56. Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.
Pea A; Yu J; Rezaee N; Luchini C; He J; Dal Molin M; Griffin JF; Fedor H; Fesharakizadeh S; Salvia R; Weiss MJ; Bassi C; Cameron JL; Zheng L; Scarpa A; Hruban RH; Lennon AM; Goggins M; Wolfgang CL; Wood LD
Ann Surg; 2017 Jul; 266(1):133-141. PubMed ID: 27433916
[TBL] [Abstract][Full Text] [Related]
57. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C
Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069
[TBL] [Abstract][Full Text] [Related]
58. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
[TBL] [Abstract][Full Text] [Related]
59. [Branch duct intraductal papillary mucinous neoplasm - surgical approach].
Kaiser J; Büchler MW; Hackert T
Chirurg; 2017 Nov; 88(11):927-933. PubMed ID: 28801818
[TBL] [Abstract][Full Text] [Related]
60. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
